跳转至内容
Merck
CN
  • Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.

Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.

Cancer research (2020-03-29)
Gianluca Selvaggio, Sara Canato, Archana Pawar, Pedro T Monteiro, Patrícia S Guerreiro, M Manuela Brás, Florence Janody, Claudine Chaouiya
摘要

Epithelial-to-mesenchymal transition (EMT) has been associated with cancer cell heterogeneity, plasticity, and metastasis. However, the extrinsic signals supervising these phenotypic transitions remain elusive. To assess how selected microenvironmental signals control cancer-associated phenotypes along the EMT continuum, we defined a logical model of the EMT cellular network that yields qualitative degrees of cell adhesions by adherens junctions and focal adhesions, two features affected during EMT. The model attractors recovered epithelial, mesenchymal, and hybrid phenotypes. Simulations showed that hybrid phenotypes may arise through independent molecular paths involving stringent extrinsic signals. Of particular interest, model predictions and their experimental validations indicated that: (i) stiffening of the extracellular matrix was a prerequisite for cells overactivating FAK_SRC to upregulate SNAIL and acquire a mesenchymal phenotype and (ii) FAK_SRC inhibition of cell-cell contacts through the receptor-type tyrosine-protein phosphatases kappa led to acquisition of a full mesenchymal, rather than a hybrid, phenotype. Altogether, these computational and experimental approaches allow assessment of critical microenvironmental signals controlling hybrid EMT phenotypes and indicate that EMT involves multiple molecular programs. SIGNIFICANCE: A multidisciplinary study sheds light on microenvironmental signals controlling cancer cell plasticity along EMT and suggests that hybrid and mesenchymal phenotypes arise through independent molecular paths.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
聚乙烯感染/转染试剂, A highly efficient method of gene transfer into mammalian cells leveraging infection with retroviral vectors.
Sigma-Aldrich
(Z)-4-羟三苯氧胺, ≥98% Z isomer
Sigma-Aldrich
抗-GAPDH 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
嘌呤霉素,二盐酸盐,经细胞培养测试, Puromycin, CAS 58-58-2, is a protein synthesis inhibitor that causes premature release of nascent polypeptide chains.